cyclohexanol has been researched along with naloxone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arend, I; Cogal, A; Flohé, L; Richter, W; Simon, W | 1 |
| Bromm, B; Herrmann, WM; Scharein, E | 1 |
| Friderichs, E; Hennies, HH; Schneider, J | 1 |
| Beutler, A; Bianchetti, MG; Ferrier, PE | 1 |
| Barth, H; Flohé, L; Giertz, H; Richter, W | 1 |
| Welch, SP | 1 |
| Brown, RE; Dastur, FN; McGregor, IS; McLellan, RA | 1 |
| Coutts, AA; Pertwee, RG | 1 |
| Gallate, JE; Mallet, PE; McGregor, IS; Saharov, T | 1 |
| Braida, D; Parolaro, D; Pozzi, M; Sala, M | 1 |
| Braida, D; Cavallini, R; Pozzi, M; Sala, M | 1 |
| De Miguel, R; Fernández, B; Gomez, N; Guaza, C; Ramos, JA; Romero, EM; Sagredo, O; Urigüen, L; Viveros, MP | 1 |
| Rao, VS; Santos, FA | 1 |
| Fortier, LP; Roy, S | 1 |
| Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Marchand, F; Pelissier, T | 1 |
| Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Jourdan, D; Marchand, F; Pelissier, T | 1 |
| Dziedzicka-Wasylewska, M; Filip, M; Inan, SY; Przegaliński, E; Wydra, K | 1 |
| Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Spano, S | 1 |
| Ahmedov, V; Gültekin, H | 1 |
| Berrocoso, E; Mico, JA | 1 |
| Craft, RM; Laggart, JD; Tsutsui, KT; Wakley, AA | 1 |
| Bujalska-Zadrożny, M; Cegielska-Perun, K; Gąsińska, E; Makulska-Nowak, HE; Tatarkiewicz, J | 1 |
| Anaya-Eugenio, GD; Bye, R; Linares, E; Mata, R; Rivero-Cruz, I | 1 |
3 trial(s) available for cyclohexanol and naloxone
| Article | Year |
|---|---|
[Clinical study on the development of dependency after long-term treatment with tramadol (author's transl)].
Topics: Analgesics; Clinical Trials as Topic; Cyclohexanols; Humans; Naloxone; Pain; Placebos; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
[Comparison of the action of 2 effective analgesics. Experimental study: tramadol versus tilidine/naloxone].
Topics: Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Cyclohexanols; Double-Blind Method; Drug Combinations; Humans; Naloxone; Pain; Pain Measurement; Random Allocation; Tilidine; Tramadol | 1989 |
Clinical investigation on the development of dependence during oral therapy with tramadol.
Topics: Administration, Oral; Adult; Aged; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naloxone; Pain; Precipitin Tests; Random Allocation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tramadol | 1985 |
20 other study(ies) available for cyclohexanol and naloxone
| Article | Year |
|---|---|
Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids.
Topics: Animals; Antitussive Agents; Brain Chemistry; Codeine; Cyclohexanols; Dose-Response Relationship, Drug; Male; Membranes; Naloxone; Narcotics; Rats; Rats, Inbred Strains; Reaction Time; Receptors, Opioid; Tramadol | 1988 |
[Acute poisoning with a narcotic (Tramadol) in an infant of five weeks].
Topics: Accidents; Administration, Rectal; Cyclohexanols; Humans; Infant; Male; Muscle Hypotonia; Naloxone; Respiratory Paralysis; Tramadol | 1988 |
Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH).
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Injections, Intraventricular; Injections, Spinal; Mice; Naloxone; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Cannabinoid modulation of rat pup ultrasonic vocalizations.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Body Temperature; Cannabinoids; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; Hypothermia; Motor Activity; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rimonabant; Vocalization, Animal | 1996 |
Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Topics: Acetylcholine; Benzoxazines; Child, Preschool; Cyclohexanols; Histamine; Humans; In Vitro Techniques; Male; Morpholines; Myenteric Plexus; Naloxone; Naphthalenes; Norepinephrine; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Stereoisomerism | 1997 |
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Topics: Animals; Beer; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drinking Behavior; Ethanol; Male; Motor Activity; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; Self Administration; Sucrose | 1999 |
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzimidazoles; Conditioning, Operant; Cyclohexanols; Heroin; Male; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration | 2001 |
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Brain; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Heroin; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reward; Rimonabant | 2001 |
Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
Topics: Analgesics; Animals; Behavior, Animal; Cannabinoids; Corticosterone; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Grooming; Male; Marijuana Abuse; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Neostriatum; Neurosecretory Systems; Nociceptors; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sex Characteristics | 2002 |
Possible role of mast cells in cineole-induced scratching behavior in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Cyclohexanols; Cyproheptadine; Diphenhydramine; Eucalyptol; Histamine H1 Antagonists; Male; Mast Cells; Mice; Monoterpenes; Naloxone; p-Methoxy-N-methylphenethylamine; Purinergic P1 Receptor Agonists; Serotonin Antagonists; Terpenes; Theophylline | 2002 |
Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.
Topics: Adult; Analgesics, Opioid; Anesthesia Recovery Period; Anesthesia, General; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Synergism; Female; Fentanyl; Humans; Muscle Rigidity; Naloxone; Narcotic Antagonists; Venlafaxine Hydrochloride | 2003 |
The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.
Topics: Analgesics; Animals; Cyclohexanols; Diabetes Complications; Dose-Response Relationship, Drug; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Pain Threshold; Pressure; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.
Topics: alpha-Methyltyrosine; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fenclonine; Male; Mononeuropathies; Motor Activity; Naloxone; Narcotic Antagonists; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Antidepressive Agents; Biogenic Monoamines; Conditioning, Operant; Cyclohexanols; Cyclopropanes; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Milnacipran; Morphine; Morpholines; Naloxone; Narcotic Antagonists; Nomifensine; Rats; Rats, Wistar; Reboxetine; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Tramadol; Venlafaxine Hydrochloride | 2004 |
Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Topics: Animals; Behavior, Addictive; Benzoxazines; Conditioning, Operant; Cyclohexanols; Drug Interactions; Extinction, Psychological; Heroin; Heroin Dependence; Male; Morpholines; Naloxone; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration | 2005 |
Role of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine.
Topics: Analgesics; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Male; Naloxone; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Wistar; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Idazoxan; Locus Coeruleus; Male; Naloxone; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Serotonin; Venlafaxine Hydrochloride | 2007 |
Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Topics: Analgesics; Animals; Camphanes; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Morphine; Motor Activity; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sex Characteristics | 2012 |
Venlafaxine and neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Diabetes Mellitus, Experimental; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Neuralgia; p-Chloroamphetamine; Pain Threshold; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Venlafaxine Hydrochloride; Yohimbine | 2013 |
Antinociceptive activity of the essential oil from Artemisia ludoviciana.
Topics: Analgesics; Animals; Artemisia; Camphanes; Camphor; Cyclohexanols; Dose-Response Relationship, Drug; Eucalyptol; Male; Mice; Monoterpenes; Motor Activity; Naloxone; Narcotic Antagonists; Oils, Volatile; Pain Measurement; Plant Components, Aerial; Rotarod Performance Test | 2016 |